封面
市場調查報告書
商品編碼
1880505

尿路動力學設備及耗材市場預測至2032年:依產品類型、技術、應用、最終用戶及地區分類的全球分析

Urodynamic Equipment and Consumables Market Forecasts to 2032 - Global Analysis By Product Type (Urodynamic Equipment, Urodynamic Consumables, and Other Product Types), Technology, Application, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究,全球尿路動力學設備和耗材市場預計在 2025 年達到 3.9933 億美元,預計到 2032 年將達到 7.2532 億美元,在預測期內複合年成長率為 8.9%。

尿路動力學設備及耗材包括一系列診斷儀器和一次性用品,用於評估膀胱和尿道儲存和排放的功能。這些系統可收集尿流率、內部壓力和肌肉反應等關鍵測量數據,以識別尿失禁、尿路阻塞和神經系統相關膀胱疾病等病症。核心儀器包括流量計、壓力測量單元、導管和分析軟體,而耗材包括一次性導管、電極、導尿管和用於確保檢測可靠性和衛生性的無菌組件。

根據美國國立衛生研究院 (NIH) 的數據,到 2023 年,美國將有約 2,500 萬成年人患有尿失禁,其中 65 歲及以上人群的盛行率約為 33%。

高齡化社會的發展

與老齡化相關的疾病,例如尿失禁、膀胱功能障礙和前列腺疾病,發病率不斷上升,因此需要更先進的診斷工具。醫院和診所擴大採用尿路動力學設備來有效管理這些慢性泌尿系統疾病。對早期發現和預防性護理的日益重視也推動了這些設備的普及。診斷準確性的技術進步正在改善患者的治療效果並減少併發症。隨著全球預期壽命的延長,人口老化仍然是市場擴張的主要驅動力。

院內感染(HAI)的風險

使用導管和診斷探針的操作本身就存在交叉感染的風險。醫療專業人員必須遵守嚴格的感染控制通訊協定,這可能導致設備使用率降低和營運成本增加。監管機構制定了嚴格的消毒和衛生標準,進一步增加了臨床工作流程的複雜性。由於資源和專業知識有限,小規模的醫療機構往往難以達到合規要求。這些與感染相關的擔憂會阻礙某些地區的市場滲透速度。

先進技術的融合

人工智慧驅動的診斷平台正在提高膀胱功能分析的準確性,並減少人為誤差。雲端基礎的數據管理系統使醫生能夠遠端監測患者的病情進展,並簡化工作流程。攜帶式和無線設備的普及使得在門診和居家照護環境中進行檢測成為可能。感測器技術的進步和微創設計的改進正在提高患者的舒適度和手術效率。這些創新正在共同重塑市場格局,並為永續成長鋪路。

其他診斷方法

超音波和磁振造影等影像技術正日益廣泛地應用於膀胱和泌尿道的評估。非侵入性穿戴裝置作為一種替代方案正在興起,無需臨床干預即可提供持續監測。這些替代方案往往更受尋求微創解決方案的患者青睞。隨著技術的進步,傳統的動態檢查工具正日益受到新型診斷方法的挑戰。若缺乏差異化和創新,傳統設備將面臨市場佔有率被這些新興技術蠶食的風險。

新冠疫情的影響:

由於擇期診斷程序的推遲,新冠肺炎疫情擾亂了尿路動力學設備和耗材市場。醫院優先保障加護治療,減少了常規泌尿系統檢查的需求。然而,疫情也加速了數位化進程,遠距泌尿系統會診和遠端監測變得普遍。緊急監管核准使得關鍵診斷工具得以快速部署。疫情後的策略強調韌性、自動化和分散式檢查,以應對未來的挑戰。

預計在預測期內,尿動力學檢測設備細分市場將佔據最大的市場佔有率。

由於尿路動力學設備在診斷複雜泌尿系統疾病方面發揮核心作用,預計在預測期內,該細分市場將佔據最大的市場佔有率。這些設備對於評估膀胱內壓、尿流率和括約肌功能至關重要。醫院和專科診所高度依賴基於設備的診斷來指南治療決策。無線尿流率測定和自動壓力感測器等技術進步提高了診斷的準確性和效率。人們對泌尿系統健康的日益重視以及患者數量的成長進一步推動了市場需求。

預計在預測期內,門診手術中心細分市場將呈現最高的複合年成長率。

由於成本效益高且方便患者,預計在預測期內,門診手術中心領域將達到最高成長率。門診手術中心擴大採用攜帶式尿動力學系統,以便在傳統醫院環境之外進行診斷。優惠的報銷政策鼓勵門診檢查,從而減輕了大型醫療機構的負擔。雲端基礎的監控和庫存管理系統正在提高這些中心的營運效率。隨著醫療保健分散化趨勢的日益成長,門診手術中心正成為泌尿系統診斷的重要樞紐。

佔比最大的地區:

預計亞太地區將在預測期內佔據最大的市場佔有率,這主要得益於醫療基礎設施的持續改善和泌尿系統疾病發病率的上升。中國、印度和日本等國家正在大力投資,以實現診斷技術和醫療設備製造的現代化。政府主導的措施正在促進本地生產,降低對進口的依賴。人工智慧輔助診斷和微創檢測的快速普及正在推動該地區的成長。全球製造商與本地分銷商之間的合作正在提高醫療服務的可近性和可負擔性。

年複合成長率最高的地區:

在預測期內,北美地區預計將實現最高的複合年成長率,這主要得益於其技術領先地位和強大的研發生態系統。美國和加拿大在智慧診斷系統和人工智慧驅動的泌尿系統平台方面處於創新主導。監管機構正在簡化核准流程,從而加快先進設備的商業化進程。醫院正在整合物聯網和數據分析技術,以最佳化診斷工作流程和病患管理。健全的報銷機制也為微創診斷技術的廣泛應用提供了支持。

免費客製化服務:

購買此報告的客戶可以選擇以下免費自訂選項之一:

  • 公司概況
    • 對其他市場公司(最多 3 家公司)進行全面分析
    • 對主要企業進行SWOT分析(最多3家公司)
  • 區域細分
    • 根據客戶要求,提供主要國家的市場估算和預測以及複合年成長率(註:可行性需確認)。
  • 競爭基準化分析
    • 根據主要企業的產品系列、地理覆蓋範圍和策略聯盟基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 原始研究資料
    • 次級研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球尿路動力學設備及耗材市場(依產品類型分類)

  • 介紹
  • 尿路動力學裝置
    • 膀胱測壓儀
    • 尿流率測量裝置
    • 肌電圖(EMG)系統
    • 視訊動態系統
    • 動態椅
    • 前列腺壓力-流量研究系統
  • 尿路動力學設備耗材
    • 導管
    • 拋棄式尿流量計
    • 感測器組
    • 電極
    • 壓力管及配件
  • 其他產品類型

6. 全球尿路動力學設備及耗材市場(依技術分類)

  • 介紹
  • 常規尿路動力學檢查設備
  • 自動化尿路動力學檢測設備
  • 無線和藍牙動態測試
  • 可攜式/手持式動態系統
  • 其他技術

7. 全球尿路動力學設備及耗材市場(依應用領域分類)

  • 介紹
  • 尿失禁
  • 良性攝護腺增生(BPH)
  • 神經源性膀胱
  • 骨盆器官脫垂
  • 膀胱過動症
  • 其他泌尿系統疾病

8. 全球尿路動力學動力學設備及耗材市場(依最終用戶分類)

  • 介紹
  • 醫院
  • 泌尿系統診所
  • 診斷中心
  • 門診手術中心
  • 其他最終用戶

9. 全球尿路動力學設備及耗材市場(按地區分類)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章:重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與併購
  • 新產品上市
  • 業務拓展
  • 其他關鍵策略

第11章 企業概況

  • Laborie
  • Teleflex
  • Natus
  • Olympus Corporation
  • MMT/Medkonsult
  • TIC Medizintechnik
  • The Prometheus Group
  • Wellspect Healthcare
  • SRS Medical
  • Cook Medical
  • Santron Meditronic
  • Medtronic
  • Verathon
  • Boston Scientific
  • Coloplast
Product Code: SMRC32569

According to Stratistics MRC, the Global Urodynamic Equipment and Consumables Market is accounted for $399.33 million in 2025 and is expected to reach $725.32 million by 2032 growing at a CAGR of 8.9% during the forecast period. Urodynamic equipment and consumables encompass a range of diagnostic devices and disposable supplies used to assess how the bladder and urethra store and release urine. These systems capture key measurements like flow rate, internal pressures, and muscular responses to identify disorders including urinary incontinence, blockages, and nerve-related bladder issues. Core devices include flowmeters, pressure measurement units, catheters, and analysis software, while consumables consist of single-use tubing, electrodes, catheters, and sterile components essential for reliable and hygienic tests.

According to the National Institutes of Health (NIH), urinary incontinence affects approximately 25 million adults in the U.S. in 2023, with nearly 33% of people aged 65 and above experiencing this condition.

Market Dynamics:

Driver:

Rising geriatric population

Age-related conditions such as urinary incontinence, bladder dysfunction, and prostate disorders are becoming more prevalent, requiring advanced diagnostic tools. Hospitals and clinics are increasingly adopting urodynamic testing to manage these chronic urological issues effectively. The growing emphasis on early detection and preventive care is further accelerating equipment utilization. Technological improvements in diagnostic precision are enhancing patient outcomes and reducing complications. As longevity increases worldwide, the geriatric demographic remains a primary driver of market expansion.

Restraint:

Risk of hospital-acquired infections (HAIs)

Procedures involving catheters and diagnostic probes carry inherent risks of cross-contamination. Healthcare providers face strict infection control protocols, which can slow down equipment usage and increase operational costs. Regulatory agencies are imposing stringent sterilization and hygiene standards, adding complexity to clinical workflows. Smaller facilities often struggle to maintain compliance due to limited resources and expertise. These infection-related concerns act as a restraint, limiting the pace of market penetration in certain regions.

Opportunity:

Integration of advanced technologies

AI-driven diagnostic platforms are improving accuracy in bladder function analysis and reducing human error. Cloud-based data management systems allow physicians to monitor patient outcomes remotely and streamline workflows. Portable and wireless devices are gaining traction, enabling testing in ambulatory and home-care settings. Advances in sensor technology and minimally invasive designs are enhancing patient comfort and procedural efficiency. Together, these innovations are reshaping the market landscape and creating avenues for sustainable growth.

Threat:

Alternative diagnostic methods

Imaging techniques such as ultrasound and MRI are increasingly used to assess bladder and urinary tract conditions. Non-invasive wearable devices are emerging as substitutes, offering continuous monitoring without clinical intervention. These alternatives often appeal to patients seeking less invasive solutions. As technology evolves, competition between traditional urodynamic tools and newer diagnostic methods is intensifying. Without differentiation and innovation, conventional equipment risks losing market share to these emerging modalities.

Covid-19 Impact:

The COVID-19 pandemic disrupted the urodynamic equipment and consumables market by delaying elective diagnostic procedures. Hospitals prioritized critical care, leading to reduced demand for routine urological testing. However, the crisis accelerated digital adoption, with tele-urology and remote monitoring gaining traction. Emergency regulatory approvals facilitated faster deployment of essential diagnostic tools. Post-pandemic strategies now emphasize resilience, automation, and decentralized testing to safeguard against future disruptions.

The urodynamic equipment segment is expected to be the largest during the forecast period

The urodynamic equipment segment is expected to account for the largest market share during the forecast period, due to its central role in diagnosing complex urinary disorders. These devices are essential for evaluating bladder pressure, urine flow, and sphincter function. Hospitals and specialized clinics rely heavily on equipment-based diagnostics to guide treatment decisions. Technological advancements such as wireless uroflowmetry and automated pressure transducers are improving accuracy and efficiency. Rising awareness of urinary health and increasing patient visits are further driving demand.

The ambulatory surgical centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ambulatory surgical centers segment is predicted to witness the highest growth rate, driven by cost-effectiveness and patient convenience. ASCs are increasingly adopting portable urodynamic systems to perform diagnostics outside traditional hospital environments. Favorable reimbursement policies are encouraging outpatient testing, reducing the burden on large healthcare facilities. Cloud-based monitoring and inventory systems are enhancing operational efficiency in these centers. The growing trend of decentralized care is positioning ASCs as vital hubs for urological diagnostics.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, supported by expanding healthcare infrastructure and rising urological disease prevalence. Countries such as China, India, and Japan are investing heavily in diagnostic modernization and medical device manufacturing. Government initiatives are promoting local production and reducing reliance on imports. Rapid adoption of AI-assisted diagnostics and minimally invasive testing is strengthening regional growth. Collaborations between global manufacturers and local distributors are improving accessibility and affordability.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its technological leadership and strong R&D ecosystem. The U.S. and Canada are pioneering innovations in smart diagnostic systems and AI-driven urology platforms. Regulatory bodies are streamlining approval pathways, enabling faster commercialization of advanced devices. Hospitals are integrating IoT and data analytics to optimize diagnostic workflows and patient management. A robust reimbursement framework supports widespread adoption of minimally invasive diagnostics.

Key players in the market

Some of the key players in Urodynamic Equipment and Consumables Market include Laborie, Teleflex, Natus, Olympus Corporation, MMT / Medkonsult, TIC Medizintechnik, The Prometheus Group, Wellspect Healthcare, SRS Medical, Cook Medical, Santron Meditronic, Medtronic, Verathon, Boston Scientific, and Coloplast.

Key Developments:

In October 2025, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on developing and commercializing innovative and minimally invasive solutions for patients with chronic pain.

In July 2025, Verathon announces the launch of GlideScope(R) ClearFit(TM), a cover-based video laryngoscope designed to deliver airway management capabilities with cost efficiency. ClearFit combines one reusable video baton with an industry-leading selection of six single-use covers, including Mac, Miller, and Hyperangle style options, to address a wide range of patient types and clinical settings.

Product Types Covered:

  • Urodynamic Equipment
  • Urodynamic Consumables
  • Other Product Types

Technologies Covered:

  • Conventional Urodynamics
  • Automated Urodynamics
  • Wireless & Bluetooth-Based Urodynamics
  • Portable/Handheld Urodynamic Systems
  • Other Technologies

Applications Covered:

  • Urinary Incontinence
  • Benign Prostatic Hyperplasia (BPH)
  • Neurogenic Bladder
  • Pelvic Organ Prolapse
  • Overactive Bladder
  • Other Urological Conditions

End Users Covered:

  • Hospitals
  • Urology Clinics
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Urodynamic Equipment and Consumables Market, By Product Type

  • 5.1 Introduction
  • 5.2 Urodynamic Equipment
    • 5.2.1 Cystometers
    • 5.2.2 Uroflowmetry Devices
    • 5.2.3 Electromyography (EMG) Systems
    • 5.2.4 Video Urodynamics Systems
    • 5.2.5 Urodynamic Chairs
    • 5.2.6 Prostate Pressure Flow Study Systems
  • 5.3 Urodynamic Consumables
    • 5.3.1 Catheters
    • 5.3.2 Disposable Uroflowmeters
    • 5.3.3 Transducer Sets
    • 5.3.4 Electrodes
    • 5.3.5 Pressure Tubing & Accessories
  • 5.4 Other Product Types

6 Global Urodynamic Equipment and Consumables Market, By Technology

  • 6.1 Introduction
  • 6.2 Conventional Urodynamics
  • 6.3 Automated Urodynamics
  • 6.4 Wireless & Bluetooth-Based Urodynamics
  • 6.5 Portable/Handheld Urodynamic Systems
  • 6.6 Other Technologies

7 Global Urodynamic Equipment and Consumables Market, By Application

  • 7.1 Introduction
  • 7.2 Urinary Incontinence
  • 7.3 Benign Prostatic Hyperplasia (BPH)
  • 7.4 Neurogenic Bladder
  • 7.5 Pelvic Organ Prolapse
  • 7.6 Overactive Bladder
  • 7.7 Other Urological Conditions

8 Global Urodynamic Equipment and Consumables Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Urology Clinics
  • 8.4 Diagnostic Centers
  • 8.5 Ambulatory Surgical Centers
  • 8.6 Other End Users

9 Global Urodynamic Equipment and Consumables Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Laborie
  • 11.2 Teleflex
  • 11.3 Natus
  • 11.4 Olympus Corporation
  • 11.5 MMT / Medkonsult
  • 11.6 TIC Medizintechnik
  • 11.7 The Prometheus Group
  • 11.8 Wellspect Healthcare
  • 11.9 SRS Medical
  • 11.10 Cook Medical
  • 11.11 Santron Meditronic
  • 11.12 Medtronic
  • 11.13 Verathon
  • 11.14 Boston Scientific
  • 11.15 Coloplast

List of Tables

  • Table 1 Global Urodynamic Equipment and Consumables Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Urodynamic Equipment and Consumables Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Urodynamic Equipment and Consumables Market Outlook, By Urodynamic Equipment (2024-2032) ($MN)
  • Table 4 Global Urodynamic Equipment and Consumables Market Outlook, By Cystometers (2024-2032) ($MN)
  • Table 5 Global Urodynamic Equipment and Consumables Market Outlook, By Uroflowmetry Devices (2024-2032) ($MN)
  • Table 6 Global Urodynamic Equipment and Consumables Market Outlook, By Electromyography (EMG) Systems (2024-2032) ($MN)
  • Table 7 Global Urodynamic Equipment and Consumables Market Outlook, By Video Urodynamics Systems (2024-2032) ($MN)
  • Table 8 Global Urodynamic Equipment and Consumables Market Outlook, By Urodynamic Chairs (2024-2032) ($MN)
  • Table 9 Global Urodynamic Equipment and Consumables Market Outlook, By Prostate Pressure Flow Study Systems (2024-2032) ($MN)
  • Table 10 Global Urodynamic Equipment and Consumables Market Outlook, By Urodynamic Consumables (2024-2032) ($MN)
  • Table 11 Global Urodynamic Equipment and Consumables Market Outlook, By Catheters (2024-2032) ($MN)
  • Table 12 Global Urodynamic Equipment and Consumables Market Outlook, By Disposable Uroflowmeters (2024-2032) ($MN)
  • Table 13 Global Urodynamic Equipment and Consumables Market Outlook, By Transducer Sets (2024-2032) ($MN)
  • Table 14 Global Urodynamic Equipment and Consumables Market Outlook, By Electrodes (2024-2032) ($MN)
  • Table 15 Global Urodynamic Equipment and Consumables Market Outlook, By Pressure Tubing & Accessories (2024-2032) ($MN)
  • Table 16 Global Urodynamic Equipment and Consumables Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 17 Global Urodynamic Equipment and Consumables Market Outlook, By Technology (2024-2032) ($MN)
  • Table 18 Global Urodynamic Equipment and Consumables Market Outlook, By Conventional Urodynamics (2024-2032) ($MN)
  • Table 19 Global Urodynamic Equipment and Consumables Market Outlook, By Automated Urodynamics (2024-2032) ($MN)
  • Table 20 Global Urodynamic Equipment and Consumables Market Outlook, By Wireless & Bluetooth-Based Urodynamics (2024-2032) ($MN)
  • Table 21 Global Urodynamic Equipment and Consumables Market Outlook, By Portable/Handheld Urodynamic Systems (2024-2032) ($MN)
  • Table 22 Global Urodynamic Equipment and Consumables Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 23 Global Urodynamic Equipment and Consumables Market Outlook, By Application (2024-2032) ($MN)
  • Table 24 Global Urodynamic Equipment and Consumables Market Outlook, By Urinary Incontinence (2024-2032) ($MN)
  • Table 25 Global Urodynamic Equipment and Consumables Market Outlook, By Benign Prostatic Hyperplasia (BPH) (2024-2032) ($MN)
  • Table 26 Global Urodynamic Equipment and Consumables Market Outlook, By Neurogenic Bladder (2024-2032) ($MN)
  • Table 27 Global Urodynamic Equipment and Consumables Market Outlook, By Pelvic Organ Prolapse (2024-2032) ($MN)
  • Table 28 Global Urodynamic Equipment and Consumables Market Outlook, By Overactive Bladder (2024-2032) ($MN)
  • Table 29 Global Urodynamic Equipment and Consumables Market Outlook, By Other Urological Conditions (2024-2032) ($MN)
  • Table 30 Global Urodynamic Equipment and Consumables Market Outlook, By End User (2024-2032) ($MN)
  • Table 31 Global Urodynamic Equipment and Consumables Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 32 Global Urodynamic Equipment and Consumables Market Outlook, By Urology Clinics (2024-2032) ($MN)
  • Table 33 Global Urodynamic Equipment and Consumables Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 34 Global Urodynamic Equipment and Consumables Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 35 Global Urodynamic Equipment and Consumables Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.